Sartorius AG (0NIQ) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Sartorius Ag.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.803 -- 00:00:06.811 Ladies and gentlemen, welcome to the Sartorius and Sartorius Ted in Biotech 00:00:06.811 -- 00:00:09.816 conference call on the first quarter 2025. 00:00:09.816 -- 00:00:14.884 I would like to remind you that all participants will be in listen-only mode 00:00:14.884 -- 00:00:17.428 and the conference has been recorded. 00:00:17.428 -- 00:00:22.496 This call is scheduled for 60 minutes. The presentation will be followed by Q&A 00:00:22.496 -- 00:00:27.380 session. In order to give all participants the opportunity to ask their question, we 00:00:27.380 -- 00:00:32.047 ask that the number of questions per person be limited to two. 00:00:32.047 -- 00:00:37.136 In addition, and in the interest of all participants, questions 00:00:37.136 -- 00:00:41.342 with the same content will only be answered once. 00:00:41.342 -- 00:00:45.810 You can register for questions at any time by pressing star and one. 00:00:45.810 -- 00:00:48.654 At this time, it's my pleasure to hand over to Dr. 00:00:48.654 -- 00:00:52.898 Joachim Kretschburg. Please go ahead, sir. 00:00:52.917 -- 00:00:58.162 Thank you very much for the introduction, and hello and welcome to 00:00:58.162 -- 00:01:02.526 our conference call on the Q1 results of Sartorius 00:01:02.526 -- 00:01:05.529 AG as well as Sartorius State in Biotech. 00:01:05.529 -- 00:01:10.834 Today, I'm together with Florian Funk, our CFO, 00:01:10.834 -- 00:01:14.157 as well as with René Faber, 00:01:14.157 -- 00:01:18.000 the president of our bioprocessing division, as well as the CEO of Sartorius State in 00:01:18.000 -- 00:01:23.136 Biotech, and also Alexandra Gatzemeier, the president of our lab division as 00:01:23.136 -- 00:01:26.902 she will walk you through the slide 00:01:26.902 -- 00:01:31.569 on the ...